Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Cigna Gains After Reaffirming Guidance, 10% EPS Growth in 2022

Published 28/12/2021, 03:46 am
© Reuters
CI
-

By Dhirendra Tripathi

Investing.com – Cigna stock (NYSE:CI) traded 1% higher Monday after the company reiterated its outlook for the ongoing financial year as well as the next.

The insurer said its officials expect to reaffirm the projections in meetings with investors and analysts over the next several weeks.

Releasing its third-quarter numbers on November 4, the company had said that it expected full-year 2021 adjusted profit from operations of at least $20.35 per share. It sees adjusted annual revenue to be at least $172 billion.

For the full-year 2022, it sees growth of at least 10% in adjusted profit from operations on a per share basis.

Total revenue for third quarter was over $44 billion, growing around 9% year-on-year. Adjusted income from operations was $5.73 per share, up 30%.

Cigna shares are up around 14% in the year against the near 28% growth in S&P 500.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.